• Source:JND

Shares of Hospital chain Park Medi World remained in focus on Thursday after the recent acquisition announcement by the North-India based hospital chain. The healthcare stock started the session in the green at 286 per share as compared to the last day's closing of Rs 284.85 on NSE. The stock maintained the gaining momentum on the back of buying interest to hit a day high at Rs 293.90, up over 3 per cent from last closing value. Last seen, the stock was trading at Rs 292.15, up 2.56 per cent or
Rs 7.30.

This move is set to bolster its footprint within the Tricity region—encompassing Mohali, Chandigarh, and Panchkula—with plans to operate the facility under the Park brand starting in November 2026.

Brokerage Initiates Buy Rating

Choice Institutional Equities has reaffirmed a 'BUY' recommendation for the stock, setting a price target of Rs 350. This represents a potential 21.6 per cent increase from the current trading value of Rs 288.

Additionally, the company has increased its presence in North India by opening The Medicity Hospital in Rudrapur, Uttarakhand. This new 330-bed multi-super speciality centre is identified by Park Group of Hospitals as the Kumaon region's largest medical facility.

Share Price History: 95% Rally This Year Till Date

The stock surged over 95 per cent till date this year despite global headwinds. In the last six months, it rose over 90 per cent.

Shares made muted market debut

On December 17, 2025, Park Medi World Ltd shares began trading on the stock exchanges with a lacklustre performance. On the BSE, the stock opened at Rs 155.60, representing a 3.95 per cent decrease from its issue price, while on the NSE, it started at Rs 158.80, a decline of 1.97 per cent.

Share Market Today

The domestic equity indices traded higher during the session on firm global cues. Last seen, Sensex--the 30-share BSE index--was trading at 78,772.18, up 0.24 per cent or 191.18 points. Nifty50 was quoted at Rs 24,628.80, up 0.017 per cent, or 4.15 points.

Disclaimer: This story is for informational purposes only. It should not be considered as investment advice.


Also In News